ADCT-502
ADCT-502-101
Phase 1 small_molecule terminated
Quick answer
ADCT-502 for Breast Cancer is a Phase 1 program (small_molecule) at ADC Therapeutics SA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ADC Therapeutics SA
- Indication
- Breast Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated